Patents by Inventor John Lidell

John Lidell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20080221026
    Abstract: The present invention provides a process for manufacture of purified Nematode-extracted Anticoagulant Proteins (NAPs), wherein the NAP manufactured by the claimed process method is a NAP drug substance that can be formulated as a NAP drug product. The present invention provides NAP drug substances and NAP drug products manufactured by the process disclosed herein. In one embodiment, the present invention provides a process for manufacture of rNAPc2/proline drug substance and rNAPc2/proline drug product, and provides rNAPc2/proline drug substance manufactured by the process disclosed herein.
    Type: Application
    Filed: June 14, 2007
    Publication date: September 11, 2008
    Applicant: Dendreon Corporation
    Inventors: Christine B. Mendoza, John Lidell, David Moss
  • Patent number: 7279309
    Abstract: The present invention provides a process for manufacture of purified Nematode-extracted Anticoagulant Proteins (NAPs), wherein the NAP manufactured by the claimed process method is a NAP drug substance that can be formulated as a NAP drug product. The present invention provides NAP drug substances and NAP drug products manufactured by the process disclosed herein. In one embodiment, the present invention provides a process for manufacture of rNAPc2/proline drug substance and rNAPc2/proline drug product, and provides rNAPc2/proline drug substance manufactured by the process disclosed herein.
    Type: Grant
    Filed: December 20, 2005
    Date of Patent: October 9, 2007
    Assignee: Dendreon Corporation
    Inventors: Christine B. Mendoza, John Lidell, David Moss
  • Publication number: 20060211086
    Abstract: The present invention provides a process for manufacture of purified Nematode-extracted Anticoagulant Proteins (NAPs), wherein the NAP manufactured by the claimed process method is a NAP drug substance that can be formulated as a NAP drug product. The present invention provides NAP drug substances and NAP drug products manufactured by the process disclosed herein. In one embodiment, the present invention provides a process for manufacture of rNAPc2/proline drug substance and rNAPc2/proline drug product, and provides rNAPc2/proline drug substance manufactured by the process disclosed herein.
    Type: Application
    Filed: December 20, 2005
    Publication date: September 21, 2006
    Inventors: Christine Mendoza, John Lidell, David Moss
  • Publication number: 20040229334
    Abstract: The present invention provides a process for manufacture of purified Nematode-extracted Anticoagulant Proteins (NAPs), wherein the NAP manufactured by the claimed process method is a NAP drug substance that can be formulated as a NAP drug product. The present invention provides NAP drug substances and NAP drug products manufactured by the process disclosed herein. In one embodiment, the present invention provides a process for manufacture of rNAPc2/proline drug substance and rNAPc2/proline drug product, and provides rNAPc2/proline drug substance manufactured by the process disclosed herein.
    Type: Application
    Filed: May 15, 2003
    Publication date: November 18, 2004
    Inventors: Christine B. Mendoza, John Lidell, David Moss